80
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Perioperative outcomes in elderly patients undergoing nephrectomy for renal cell carcinoma

, , , , & ORCID Icon
Pages 195-199 | Published online: 23 Jul 2019

References

  • United Nations Department of Economic and Social Affairs Population Division. World Population Ageing 2017 – Highlights (ST/ESA/SER.A/397); 2017 Available from: http://www.un.org/en/development/desa/population/publications/pdf/ageing/WPA2017_Highlights.pdf. Accessed 1 May, 2019.
  • Wirasorn K, Suwanrungruang K, Sookprasert A, Limpawattana P, Sirithanaphol W, Chindaprasirt J. Hospital-based population of elderly cancer cases in Northeastern Thailand. Asian Pac J Cancer Prev. 2016;17(2):767–770. doi:10.7314/apjcp.2016.17.2.76726925677
  • Saad AM, Gad MM, Al-Husseini MJ, Ruhban IA, Sonbol MB, Ho TH. Trends in renal-cell carcinoma incidence and mortality in the United States in the last 2 decades: a SEER-based study. Clin Genitourin Cancer. 2019;17(1):46–57 e45. doi:10.1016/j.clgc.2018.10.00230391138
  • Colombo JR Jr., Haber GP, Jelovsek JE, Lane B, Novick AC, Gill IS. Seven years after laparoscopic radical nephrectomy: oncologic and renal functional outcomes. Urology. 2008;71(6):1149–1154. doi:10.1016/j.urology.2007.11.08118313111
  • Flanigan RC, Salmon SE, Blumenstein BA, et al. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. N Engl J Med. 2001;345(23):1655–1659. doi:10.1056/NEJMoa00301311759643
  • Mickisch GH, Garin A, van Poppel H, et al. Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial. Lancet. 2001;358(9286):966–970. doi:10.1016/s0140-6736(01)06103-711583750
  • Lowrance WT, Yee DS, Savage C, et al. Complications after radical and partial nephrectomy as a function of age. J Urol. 2010;183(5):1725–1730. doi:10.1016/j.juro.2009.12.10120299040
  • Stephenson AJ, Hakimi AA, Snyder ME, Russo P. Complications of radical and partial nephrectomy in a large contemporary cohort. J Urol. 2004;171(1):130–134. doi:10.1097/01.ju.0000101281.04634.1314665860
  • Bensalah K, Sadiq A, Guille F, Lobel B, Patard JJ. [Risks and benefits of total nephrectomy in elderly patients over the age of 80]. Prog Urol. 2005;15(4):632–635.16459676
  • Gao X, Hu L, Pan Y, Zheng L. Surgical outcomes of nephrectomy for elderly patients with renal cell carcinoma. Pak J Med Sci. 2018;34(2):288–293. doi:10.12669/pjms.342.1406229805395
  • Staehler M, Haseke N, Stadler T, et al. Renal surgery in the elderly: morbidity in patients aged >75 years in a contemporary series. BJU Int. 2008;102(6):684–687. doi:10.1111/j.1464-410X.2008.07794.x18510657
  • American Society of Anesthesiologists. New classification of physical status. Anesthesiology. 1963;24:111.
  • Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120(4):c179–c184. doi:10.1159/00033978922890468
  • Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31–41. doi:10.1159/0001805801244564
  • Scandroglio AM, Finco G, Pieri M, et al. Cardiac surgery in 260 octogenarians: a case series. BMC Anesthesiol. 2015;15:15. doi:10.1186/s12871-015-0044-625685057
  • Tzeng CW, Cooper AB, Vauthey JN, Curley SA, Aloia TA. Predictors of morbidity and mortality after hepatectomy in elderly patients: analysis of 7621 NSQIP patients. HPB (Oxford). 2014;16(5):459–468. doi:10.1111/hpb.1215524033514
  • Yu X, Yan YC, Chen G, Yu H. The efficacy and safety of totally laparoscopic hepatectomy for non-cirrhotic hepatocellular carcinoma in the elderly. BMC Surg. 2018;18(1):118. doi:10.1186/s12893-018-0444-x30558594
  • Angulo J, El Assar M, Rodriguez-Manas L. Frailty and sarcopenia as the basis for the phenotypic manifestation of chronic diseases in older adults. Mol Aspects Med. 2016;50:1–32. doi:10.1016/j.mam.2016.06.00127370407
  • Chindapasirt J. Sarcopenia in cancer patients. Asian Pac J Cancer Prev. 2015;16(18):8075–8077. doi:10.7314/apjcp.2015.16.18.807526745041
  • Karakiewicz PI, Jeldres C, Suardi N, et al. Age at diagnosis is a determinant factor of renal cell carcinoma-specific survival in patients treated with nephrectomy. Can Urol Assoc J. 2008;2(6):610–617. doi:10.5489/cuaj.97819066680
  • Palumbo C, Cyr SJ, Mazzone E, et al. Impact of tumor size on cancer-specific mortality rate after local tumor ablation in T1a renal-cell carcinoma. J Endourol. 2019. doi:10.1089/end.2019.0179
  • Ficarra V, Novara G, Secco S, et al. Preoperative aspects and dimensions used for an anatomical (PADUA) classification of renal tumours in patients who are candidates for nephron-sparing surgery. Eur Urol. 2009;56(5):786–793. doi:10.1016/j.eururo.2009.07.04019665284